Just Diagnosed With DCIS While on HRT — Do You Have to Stop?
You're in the hospital car park. Two words have just crashed into each other in your head — DCIS, and HRT — and the only question you can actually form is this one: do I have to stop my hormones? Right now?
I'm a breast surgeon and a menopause specialist, and more and more women are asking me exactly that. The answer I give them surprises most of them. Right now, today, nobody can tell you yet. Here's why — and what happens next.
Watch the video
Just Diagnosed With DCIS While on HRT — Do You Have to Stop?
This post is the written version of my video. If you'd rather listen, it's all there in about twelve minutes.
Watch on YouTube →The diagnosis isn't finished yet
The scariest part of a DCIS diagnosis often isn't the word cancer. It's the maths you start doing in your head.
Someone told you the biopsy showed something called DCIS — ductal carcinoma in situ. Maybe they said the reassuring parts: early, non-invasive, very treatable. And maybe you heard about half of it, because somewhere in that sentence your brain had already jumped to the HRT. To the patches or the gel or the tablets that gave you back your sleep, your temper, your sex life, your brain. The version of you that could think straight again.
And then the cold little thought arrived. Did I do this to myself? Have I been feeding this thing?
So now two things you care about are sitting on opposite sides of a table. On one side, a body you want free of cancer. On the other, the hormones that gave you your life back. It feels like you have to choose one and betray the other, before you even understand what you're dealing with.
You don't have to choose anything tonight. Not one thing. The diagnosis you've been given isn't finished yet.
Your biopsy is a keyhole, not the whole room
When you had your biopsy, someone took a core — a few thin threads of tissue, through a needle, from the spot that showed up on your mammogram, ultrasound or MRI. Those threads went to the lab, and the lab told you what it saw in them.
But the area of concern might be the size of a grape, or a bit bigger. The needle sampled a sliver of it. So the report is a look through a keyhole into one room of a much bigger house. What the pathologist told you is completely true for the tissue they were given. What they can't tell you is what's in the rest of the house, because nobody has been in the rest of the house yet.
Your biopsy is a brilliant first look. It isn't the final word. And when the question is something as big as your HRT, we don't make that call on a keyhole view.
The report that decides: your final histology
There's a second report coming, and it's the one that matters here. It's called the final histology, and it only exists after surgery — once the whole area has been removed and the pathologist can examine all of it. The whole house, not the keyhole.
That report tells us what you're dealing with. Whether it's pure DCIS — cells still sitting quietly inside the milk ducts, not invading anywhere — or whether, somewhere in that tissue, there's a small area of invasive cancer that the needle happened to miss.
I know how frustrating that is when you want an answer today. You've been handed a diagnosis, and now I'm telling you to wait for a fuller one. A week or two of not knowing is bloody uncomfortable. Making the wrong call on half the information is worse.
How often the biopsy and the final result disagree
When a biopsy shows DCIS, the final histology sometimes finds a small area of invasive cancer the needle simply missed. We call that upstaging.
How often depends a lot on what the DCIS looks like. For low-grade DCIS it's around 1 in 10 — 10.8% in one large Italian series of 295 women (Nicosia et al., 2022), and 6–10% among women who would have qualified for the low-risk DCIS surveillance trials (Grimm et al., 2017). For high-grade DCIS, and for larger areas, it's higher. Pooled across 52 studies, about 1 in 4 DCIS diagnoses on a core biopsy turned out to include invasive cancer (Brennan et al., 2011: 25.9%), with high grade and a size over 20 mm both pushing the figure up.
What these numbers don't tell you: which group you're in. They're averages across thousands of women, from different hospitals, using different biopsy needles — the older, smaller needles miss more than the vacuum-assisted biopsies used now. Your own grade and size on your report give you a much better idea than any of them. Ask your surgeon where you sit.
None of this is meant to frighten you. It's the opposite. It's exactly why I won't have you rip your patches off on day one — because the answer to "should I stop my HRT" is different depending on which of two paths you're on, and until the final histology is back, nobody knows which path is yours.
If it stays pure DCIS
Say the final histology comes back and it's pure DCIS. No invasion.
That means the cells are still contained inside the ducts — stage zero. By definition, pure DCIS can't spread to the rest of your body, because it hasn't broken out of the plumbing it started in. That's why we treat it so effectively, and why the outlook is so good.
And here's the thing you came for. In my practice, pure DCIS is not on its own a reason to stop your HRT. Continuing is always on the table, and for most women it's the right call. We treat the DCIS properly, and you keep the treatment that's letting you live well. You get to keep both.
I'll be straight with you, though: not all breast surgeons or oncologists see it the same way, and after talking it through, you might decide differently. That's your decision to make, with your own team.
Second opinions are normal and appropriate.
Where you live changes this
In New Zealand and Australia, DCIS isn't routinely tested for oestrogen receptors, and hormone-blocking tablets for DCIS aren't standard practice. In the US and the UK, DCIS is usually tested and a tablet such as tamoxifen is often offered. If you've been offered one, ask your team how it fits with your HRT — the two work in opposite directions, so it's a fair question.
If it turns out to be invasive
If the final histology shows an invasive component, the conversation changes. But it's a conversation, not a reflex.
I won't pretend it isn't a bigger conversation, because it is. What I'm not saying is that invasive means stopping everything the same afternoon. This is where we sit down and weigh it up properly: your cancer's hormone receptor status, how severe your menopause symptoms are, what you'd be trading if you came off, and what non-hormonal options there are if we change course. It becomes an individual decision, made with your breast team and your oncologist, with the facts in front of everyone.
For most women whose invasive cancer is oestrogen receptor positive, we slowly stop the HRT, treat the symptoms with non-hormonal options, and reassess how you feel.
So the two paths lead to two different answers. Which is exactly why you shouldn't decide on your own, on a core biopsy result, which path you're on.
What to do while you wait
- Don't panic-stop your HRT. Stopping it tonight doesn't treat anything. It can hand you a wall of menopause symptoms two or three weeks later, on top of the hardest few weeks you've had in ages — and it changes nothing about the DCIS.
- Write down one question for your breast team.
"At this stage, is this pure DCIS, or is there an invasive component?"
Ask it now, about your core biopsy, and ask it again when the final histology is back. That answer tells you which path you're on, and the HRT question follows from it.
- Let yourself not know for a little while. The waiting is the hardest part. But you're not waiting on nothing. You're waiting on the one report that lets you make this decision properly, instead of in a panic.
Stopping your HRT on a core biopsy result doesn't treat the DCIS. The decision that matters waits for the final histology. It is entirely appropriate to ask your team to wait for it too.
You walked into that car park thinking you had to choose between your health and feeling like yourself. Wait for the full picture. Then decide which way you'd like to go.
You have time. Ask the question. Then make the decision yourself.
The video
Just Diagnosed With DCIS While on HRT — Do You Have to Stop?
The keyhole, the final histology, the two paths and the three things to do tonight — if you'd rather watch, or want to send it to someone going through this.
Watch on YouTube →Read next
- I Just Got Diagnosed with DCIS — What Happens Next?
- DCIS and HRT — Can I Still Take Hormone Therapy?
Sources
- Pooled upstaging across 52 studies: Brennan ME et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011;260:119–28.
- Low-grade DCIS: Nicosia L et al. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade DCIS of the breast. Cancers 2022;14:370.
- Low-risk DCIS: Grimm LJ et al. Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol 2017;24:3534–40.
This article is general information, not personal medical advice. Every diagnosis is different — talk through your own DCIS result and your HRT with your own breast team.